2022 Society of Gynecologic Oncology meeting report

Nasioudis, Dimitrios; Ramírez, Pedro T.

doi:10.1136/ijgc-2022-003672

Cited by 2 publications

(1 citation statement)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The only randomized controlled trial comparing minimally invasive with open surgery in patients undergoing radical hysterectomy for cervical cancer did not report peritoneal carcinomatosis as an independent outcome in the original publication 2. However, recently at the Society of Gynecologic Oncology annual meeting in 2022, an update was presented, showing that peritoneal carcinomatosis occurred in 24% of patients undergoing minimally invasive surgery, compared with zero cases in the open surgery arm 51 52…”

Section: Discussionmentioning

confidence: 99%

Peritoneal carcinomatosis after minimally invasive surgery versus open radical hysterectomy: systematic review and meta-analysis

Hoegl¹,

Viveros‐Carreño

Palacios

et al. 2022

Int J Gynecol Cancer

View full text Add to dashboard Cite

ObjectiveTo assess the incidence of peritoneal carcinomatosis in patients undergoing minimally invasive or open radical hysterectomy for cervical cancer.MethodsThe MEDLINE (accessed through Ovid), Embase, Cochrane Central Register of Controlled Trials (CENTRAL), Clinical Trials, and Scopus databases were searched for articles published from inception up to April 2022. Articles published in English were considered. The included studies reported on patients with International Federation of Gynecology and Obstetrics (FIGO) 2009 stage IA-IIA squamous cell carcinoma, adenocarcinoma, and/or adenosquamous carcinoma of the cervix who underwent primary surgery. Studies had to report at least one case of peritoneal carcinomatosis as a recurrence pattern, and only studies comparing recurrence after minimally invasive surgery versus open surgery were considered. Variables of interest were manually extracted into a standardized electronic database. This study was registered in PROSPERO (CRD42022325068).ResultsThe initial search identified 518 articles. After the removal of the duplicate entries from the initial search, two authors independently reviewed the titles and abstracts of the remaining 453 articles. Finally, 78 articles were selected for full-text evaluation; 22 articles (a total of 7626 patients) were included in the analysis—one randomized controlled trial and 21 observational retrospective studies. The most common histology was squamous cell carcinoma in 60.9%, and the tumor size was <4 cm in 92.8% of patients. Peritoneal carcinomatosis pattern represented 22.2% of recurrences in the minimally invasive surgery approach versus 8.8% in open surgery, accounting for 15.5% of all recurrences. The meta-analysis of observational studies revealed a statistically significant higher risk of peritoneal carcinomatosis after minimally invasive surgery (OR 1.90, 95% CI 1.32 to 2.74, p<0.05).ConclusionMinimally invasive surgery is associated with a statistically significant higher risk of peritoneal carcinomatosis after radical hysterectomy for cervical cancer compared with open surgery.

show abstract

Section: Discussionmentioning

confidence: 99%

Peritoneal carcinomatosis after minimally invasive surgery versus open radical hysterectomy: systematic review and meta-analysis

Hoegl¹,

Viveros‐Carreño

Palacios

et al. 2022

Int J Gynecol Cancer

View full text Add to dashboard Cite

show abstract

Efficacy and Safety of Sintilimab Plus Albumin-Bound-Paclitaxel in Patients with Advanced Cervical Cancer: A Multicenter, Open-Label, Single-Arm, Phase II Trial

Wang

Zhao

Liang

et al. 2023

Preprint

View full text Add to dashboard Cite

2022 Society of Gynecologic Oncology meeting report

Cited by 2 publications

References 37 publications

Peritoneal carcinomatosis after minimally invasive surgery versus open radical hysterectomy: systematic review and meta-analysis

Peritoneal carcinomatosis after minimally invasive surgery versus open radical hysterectomy: systematic review and meta-analysis

Efficacy and Safety of Sintilimab Plus Albumin-Bound-Paclitaxel in Patients with Advanced Cervical Cancer: A Multicenter, Open-Label, Single-Arm, Phase II Trial

Contact Info

Product

Resources

About

2022 Society of Gynecologic Oncology meeting report

Cited by 2 publications

References 37 publications

Peritoneal carcinomatosis after minimally invasive surgery versus open radical hysterectomy: systematic review and meta-analysis

Peritoneal carcinomatosis after minimally invasive surgery versus open radical hysterectomy: systematic review and meta-analysis

Efficacy and Safety of Sintilimab&nbsp;Plus Albumin-Bound-Paclitaxel in Patients with Advanced Cervical Cancer: A Multicenter, Open-Label, Single-Arm, Phase II Trial

Contact Info

Product

Resources

About

Efficacy and Safety of Sintilimab Plus Albumin-Bound-Paclitaxel in Patients with Advanced Cervical Cancer: A Multicenter, Open-Label, Single-Arm, Phase II Trial